Literature DB >> 12628004

The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.

Vilborg Matre1, Per I Høvring, Ase-Karine Fjeldheim, Lars Helgeland, Christophe Orvain, Kristin B Andersson, Kaare M Gautvik, Odd S Gabrielsen.   

Abstract

Thyrotropin-releasing hormone (TRH) receptor (TRHR) is a G-protein-coupled receptor playing a crucial role in the anterior pituitary where it controls the synthesis and secretion of thyroid-stimulating hormone and prolactin. Its widespread presence not only in the central nervous system, but also in peripheral tissues, including thymus, indicates other important, but unknown, functions. One hypothesis is that the neuropeptide TRH could play a role in the immune system. We report here that the human TRHR promoter contains 11 putative response elements for the haematopoietic transcription factor c-Myb and is highly Myb-responsive in transfection assays. Analysis of Myb binding to putative response elements revealed one preferred binding site in intron 1 of the receptor gene. Transfection studies of promoter deletions confirmed that this high-affinity element is necessary for efficient Myb-dependent transactivation of reporter plasmids in CV-1 cells. The Myb-dependent activation of the TRHR promoter was strongly suppressed by expression of a dominant negative Myb-Engrailed fusion. In line with these observations, reverse transcriptase PCR analysis of rat tissues showed that the TRHR gene is expressed both in thymocytes and bone marrow. Furthermore, specific, high-affinity TRH agonist binding to cell-surface receptors was demonstrated in thymocytes and a haematopoietic cell line. Our findings imply a novel functional link between the neuroendocrine and the immune systems at the level of promoter regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628004      PMCID: PMC1223435          DOI: 10.1042/BJ20030057

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Thyrotropin-releasing hormone.

Authors:  R O'Leary; B O'Connor
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

2.  TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1.

Authors:  B F O'Dowd; D K Lee; W Huang; T Nguyen; R Cheng; Y Liu; B Wang; M C Gershengorn; S R George
Journal:  Mol Endocrinol       Date:  2000-01

3.  Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.

Authors:  C Naper; J T Vaage; D Lambracht; G Løvik; G W Butcher; K Wonigeit; B Rolstad
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

4.  Sequence selectivity of c-Myb in vivo. Resolution of a DNA target specificity paradox.

Authors:  K B Andersson; T Berge; V Matre; O S Gabrielsen
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 5.  Molecular and cellular biology of thyrotropin-releasing hormone receptors.

Authors:  M C Gershengorn; R Osman
Journal:  Physiol Rev       Date:  1996-01       Impact factor: 37.312

6.  Distribution of thyrotropin-releasing hormone receptor mRNA in rat peripheral tissues.

Authors:  S Fukusumi; K Ogi; H Onda; S Hinuma
Journal:  Regul Pept       Date:  1995-05-30

7.  A central role for a single c-Myb binding site in a thymic locus control region.

Authors:  K C Ess; T L Whitaker; G J Cost; D P Witte; J J Hutton; B J Aronow
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M.

Authors:  M Oelgeschläger; J Krieg; J M Lüscher-Firzlaff; B Lüscher
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

Review 10.  Myb: an old oncoprotein with new roles.

Authors:  M A Thompson; R G Ramsay
Journal:  Bioessays       Date:  1995-04       Impact factor: 4.345

View more
  4 in total

Review 1.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

2.  The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.

Authors:  Marta García; Raquel Barrio; Montserrat García-Lavandeira; Angela R Garcia-Rendueles; Adela Escudero; Esther Díaz-Rodríguez; Darya Gorbenko Del Blanco; Ana Fernández; Yolanda B de Rijke; Elena Vallespín; Julián Nevado; Pablo Lapunzina; Vilborg Matre; Patricia M Hinkle; Anita C S Hokken-Koelega; María P de Miguel; José Manuel Cameselle-Teijeiro; Manuel Nistal; Clara V Alvarez; José C Moreno
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 3.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

4.  Hypothalamic neurohormones and immune responses.

Authors:  J Luis Quintanar; Irene Guzmán-Soto
Journal:  Front Integr Neurosci       Date:  2013-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.